- Home
- TRI vs GSK Comparison
TRI vs GSK Comparison
Compare TRI & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRI
- GSK
- Stock Information
- Founded
- TRI 1851
- GSK 1715
- Country
- TRI Canada
- GSK United Kingdom
- Employees
- TRI N/A
- GSK N/A
- Industry
- TRI
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- TRI
- GSK Health Care
- Exchange
- TRI Nasdaq
- GSK Nasdaq
- Market Cap
- TRI 80.0B
- GSK 71.7B
- IPO Year
- TRI N/A
- GSK N/A
- Fundamental
- Price
- TRI $187.03
- GSK $36.86
- Analyst Decision
- TRI Hold
- GSK Hold
- Analyst Count
- TRI 8
- GSK 4
- Target Price
- TRI $182.25
- GSK $47.00
- AVG Volume (30 Days)
- TRI 754.3K
- GSK 5.7M
- Earning Date
- TRI 05-01-2025
- GSK 04-30-2025
- Dividend Yield
- TRI 1.27%
- GSK 4.33%
- EPS Growth
- TRI N/A
- GSK N/A
- EPS
- TRI 4.78
- GSK 0.98
- Revenue
- TRI $7,273,000,000.00
- GSK $40,735,668,430.00
- Revenue This Year
- TRI $4.66
- GSK $7.19
- Revenue Next Year
- TRI $8.04
- GSK $5.34
- P/E Ratio
- TRI $39.52
- GSK $18.10
- Revenue Growth
- TRI 4.78
- GSK 2.57
- 52 Week Low
- TRI $150.01
- GSK $31.72
- 52 Week High
- TRI $189.89
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- TRI 63.94
- GSK 45.96
- Support Level
- TRI $180.72
- GSK $38.59
- Resistance Level
- TRI $189.28
- GSK $39.23
- Average True Range (ATR)
- TRI 3.10
- GSK 0.77
- MACD
- TRI 0.37
- GSK 0.01
- Stochastic Oscillator
- TRI 74.37
- GSK 23.14
About TRI Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008. In 2021, Thomson Reuters completed the sale of Refinitiv to LSE Group. Thomson Reuters' three largest segments are its legal professionals, Tax and accounting, and corporates segments. Legal professionals is about 42% of the firm's revenue and 47% of the firm's adjusted EBITDA. Tax and accounting makes up about 20%-25% of the firm's revenue and EBITDA. Corporates, which consists of legal professionals and tax and accounting products sold to corporations, also makes up about 20%-25% of the firm's revenue and EBITDA. Thomson Reuters' smaller segments include its Reuters news business and global print business.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.